How is the Mersana Therapeutics Inc today?

The Mersana Therapeutics Inc today is trading in the down by -5.41% at 0.35.

How has Mersana Therapeutics Inc performed historically?

The Mersana Therapeutics Inc is currently trading down -5.41% on an intraday basis in the past week the index fell 0.00%. The index has been down -32.69% in the past quarter and fell -84.98% in the past year. You can view this in the overview section.

What is Mersana Therapeutics Inc Annual Revenue?

Mersana Therapeutics Inc Annual Revenue rose 9.88%, in the last year to $40.5 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Mersana Therapeutics Inc Annual Net Profit?

Mersana Therapeutics Inc Annual Net Profit rose 59.69% in the last year to $69.19 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Mersana Therapeutics Inc Price to Earning Ratio?

Mersana Therapeutics Inc Price to Earning Ratio is -0.59, which is negative.

What is Mersana Therapeutics Inc Stock Price?

Mersana Therapeutics Inc Stock Price fell 84.98% and underperformed its sector by 111.52% in the past year.

What is Mersana Therapeutics Inc Quarterly Revenue?

Mersana Therapeutics Inc Quarterly Revenue fell 70.21% YoY to $2.75 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Mersana Therapeutics Inc Quarterly Net profit?

Mersana Therapeutics Inc Quarterly Net profit fell 24.95% YoY to $24.12 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Mersana Therapeutics Inc Return on Equity(ROE)?

Mersana Therapeutics Inc Return on Equity(ROE) for the last financial year was -505.14%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Mersana Therapeutics Inc Mutual Fund Holding?

Mersana Therapeutics Inc Mutual Fund Holding decreased by 1.03% in the last quarter to 22.9.

What is Mersana Therapeutics Inc Promoter Share Holding?

Mersana Therapeutics Inc Promoter Share Holding stayed the same in the most recent quarter at 3.43%.

What is Mersana Therapeutics Inc Interest Coverage Ratio?

Mersana Therapeutics Inc Interest Coverage Ratio is -16.75, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Mersana Therapeutics Inc Institutional Holding?

Mersana Therapeutics Inc Institutional Holding decreased by 19.18% in the last quarter to 66.53.

Mersana Therapeutics Inc XNAS: MRSN

Mersana Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Mersana Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Mersana Therapeutics Inc
Rating: 0.96725
Author: Trendlyne DVM scores

about

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms ...

0.35 -0.02 (-5.41%)

87.63% Fall from 52W High

3.5M XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Mersana Therapeutics Inc is on 11 Jun 2025 for the purpose of Mersana Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

14.0 / 100

Technically Bearish

24.7 / 100

1Yr Price target upside is 1126%

7 analysts

Mersana Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mersana Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms ...

87.63% Fall from 52W High

SWOT Analysis

Mersana Therapeutics Inc Live Price Chart

Mersana Therapeutics Inc FAQ

How is Mersana Therapeutics Inc today?

Mersana Therapeutics Inc today is trading in the red, and is down by -5.41% at 0.35.

How has Mersana Therapeutics Inc performed historically?

Mersana Therapeutics Inc is currently trading down -5.41% on an intraday basis. In the past week the stock fell 0.00%. stock has been down -32.69% in the past quarter and fell -84.98% in the past year. You can view this in the overview section.